April 2, 2026
Treatment Guide
CAR-T Therapy in China: What Foreign Patients Should Know
A guide to CAR-T cell therapy for lymphoma in China — how it works, who may be eligible, what the treatment process involves for international patients, and why a structured second opinion matters before deciding.
ChinaMed Waypoint
Read Full Article
Key Highlights
- Step-by-step explanation of the CAR-T therapy process from cell collection to monitoring
- Which types of lymphoma are most commonly considered for CAR-T
- Why eligibility is strict and CAR-T is not a first-line treatment
- Key risks including cytokine release syndrome (CRS) and how hospitals manage them
- How to prepare medically and logistically for a CAR-T treatment visit to China
Important Facts
- CAR-T therapy in China is available to eligible foreign patients, but requires thorough clinical evaluation before any treatment is arranged
- Most patients begin with a remote second opinion or MDT review before traveling to determine suitability
- Post-infusion monitoring requires staying near the treating hospital — travel planning must account for this
- A well-informed, unhurried approach to decision-making is more important than speed